Summary
Updated Aug 31, 2026
Nancy Lee Boman is Chief Regulatory Officer of Vera Therapeutics, Inc. (VERA). 1 SEC Form 4 filing on record, dated 5 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Nancy Lee Boman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Lee Boman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Marshall Fordyce - $5.76M of VERA open-market activity in the last 12 months
- William D. Turner - $1.45M of VERA open-market activity in the last 12 months
- Joseph R. Young - $567K of VERA open-market activity in the last 12 months
- Sean Grant - $208K of VERA open-market activity in the last 12 months
- David Lee Johnson - $108K of VERA open-market activity in the last 12 months
- Jason S. Carter - $107K of VERA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Nancy Lee Boman?
Nancy Lee Boman is a corporate insider, tracked as Chief Regulatory Officer of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nancy Lee Boman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Nancy Lee Boman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Nancy Lee Boman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
